Brief: SK Holdings Says Sold Shares In SK Biopharmaceuticals In Block Deal Worth $991 Mln
23/02/2021 23:28
Feb 24 (Reuters) -
* SK HOLDINGS SAYS SOLD SHARES IN SK BIOPHARMACEUTICALS IN
BLOCK
DEAL WORTH 1.1 TRILLION WON ($991.43 million)
Source text for Eikon: https://bit.ly/3dFwJYN
Further company coverage: 034730.KS
($1 = 1,109.5100 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on SK Biopharmaceuticals
See all newsBrief: Sk Biopharmaceuticals Co Signs Licensing-In Contract With 1St Biotherapeutics
US FDA pauses new enrollment in Biohaven's epilepsy drug trials (updated)
US FDA pauses new enrollment in Biohaven's epilepsy drug trials
Biohaven jumps on SK Biopharma epilepsy licensing deal worth up to $795 million
U.S. STOCKS ON THE MOVE-Meta, Kohl's, J.M. Smucker